Evaluating the Effects of a Computerized Training Program Coupled With Cognitive Behavioral Therapy (CBT) for OCD.
Personalized Computerized Inhibitory Control Training for OCD
1 other identifier
interventional
100
1 country
1
Brief Summary
This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2019
CompletedFirst Posted
Study publicly available on registry
February 27, 2019
CompletedStudy Start
First participant enrolled
April 11, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 1, 2022
March 1, 2022
4.9 years
February 25, 2019
March 21, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Obsessive-compulsive symptoms measured after 3 weeks of treatment
Measured by Yale-Brown Obsessive Compulsive Scale (YBOCS), considered the gold standard assessment tool. Y-BOCS comprises a Symptom Checklist and Severity Scale to consecutively rate obsessions and compulsions. The Checklist includes 54 common obsessions and compulsive behaviors, which are grouped according to thematic content. Symptoms that are endorsed over the past week are then globally rated by the clinician using a five-point scale ranging from 0 (none) to 4 (extreme) across five dimensions: (1) time/frequency, (2) interference, (3) distress, (4) resistance, and (5) degree of control. Obsessive and compulsive symptom severity are rated separately (scores range from 0 to 25) with these scores summed to create a total OCD severity score (range, 0-50). Symptom severity scores: mild symptoms (0-13), moderate symptoms (14-25), moderate-severe symptoms (26-34), and severe symptoms (35-40).26
3 weeks
Study Arms (1)
CBT + Personalized Computer Program
EXPERIMENTALCognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy and training with a personalized computerized inhibitory training program
Interventions
Training with a personalized computerized inhibitory training program
Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy
Eligibility Criteria
You may qualify if:
- Principal diagnosis of OCD (assessed by SCID).
- Clinically significant OCD symptoms (Y-BOCS score of at least 14).
- Allowed to be on medications if they have been on a stable dose for at least 12 weeks prior to the study and will remain on a stable dose during this study.
- Have access to a computer or laptop.
You may not qualify if:
- Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID).
- Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system.
- Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry.
- Patients with a history of more than 8 hours of therapist-assisted ERP for OCD in the past 6 months,
- Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded).
- Active suicidality warranting immediate clinical care.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hebrew University of Jerusalem
Jerusalem, 9190501, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Noa Tauber, MA
Hebrew University of Jerusalem
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 25, 2019
First Posted
February 27, 2019
Study Start
April 11, 2019
Primary Completion
March 1, 2024
Study Completion
June 1, 2024
Last Updated
April 1, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share